Charles Schwab Investment Management Inc. Grows Holdings in Privia Health Group, Inc. $PRVA

Charles Schwab Investment Management Inc. lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 5.2% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,192,362 shares of the company’s stock after purchasing an additional 58,489 shares during the period. Charles Schwab Investment Management Inc. owned about 0.98% of Privia Health Group worth $26,769,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Durable Capital Partners LP grew its holdings in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock worth $224,587,000 after purchasing an additional 378,255 shares during the last quarter. Van Berkom & Associates Inc. bought a new position in shares of Privia Health Group in the first quarter worth approximately $45,207,000. Nuveen Asset Management LLC grew its holdings in shares of Privia Health Group by 19.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company’s stock worth $29,110,000 after purchasing an additional 246,393 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Privia Health Group by 10.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,416,235 shares of the company’s stock worth $27,687,000 after purchasing an additional 138,747 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Privia Health Group by 14.2% in the fourth quarter. Northern Trust Corp now owns 1,392,641 shares of the company’s stock worth $27,226,000 after purchasing an additional 173,563 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on PRVA shares. Evercore ISI cut their target price on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a report on Wednesday, July 9th. Barclays raised their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 27th. JPMorgan Chase & Co. raised their target price on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an “overweight” rating in a report on Wednesday, May 28th. JMP Securities reiterated a “market outperform” rating and issued a $29.00 price target on shares of Privia Health Group in a report on Monday, April 28th. Finally, Piper Sandler cut their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Privia Health Group has an average rating of “Buy” and an average price target of $28.00.

Privia Health Group Trading Down 0.3%

Shares of Privia Health Group stock opened at $21.15 on Thursday. The firm has a market capitalization of $2.60 billion, a P/E ratio of 192.29, a P/E/G ratio of 3.07 and a beta of 0.80. The business has a fifty day simple moving average of $20.98 and a two-hundred day simple moving average of $22.72. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to analysts’ expectations of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. Analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.